NSCLC - IMMUNOTHERAPY, SCLC AND MESOTHELIOMA
Invited Discussant, Abstracts 1180PD, 1181PD, 1521PD and 1192PD
B. Besse
Invited Discussant, Abstracts 1180PD, 1181PD, 1521PD and 1192PD
B. Besse